300841 康華生物
按盤價 
75.330 -0.990 (-1.297%)
75.330 -0.990 (-1.297%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.329 | 11.453 | 15.455 | 20.817 | 35.717 |
| 總資產報酬率 ROA (%) | 2.912 | 9.680 | 12.858 | 17.776 | 32.115 |
| 投入資產回報率 ROIC (%) | 3.167 | 10.832 | 14.665 | 20.247 | 35.622 | 邊際利潤分析 |
| 銷售毛利率 (%) | 92.783 | 94.203 | 93.453 | 93.562 | 93.520 |
| 營業利潤率 (%) | 25.942 | 32.634 | 36.555 | 47.383 | 70.855 |
| 息稅前利潤/營業總收入 (%) | 25.366 | 32.019 | 35.885 | 46.507 | 69.205 |
| 淨利潤/營業總收入 (%) | 23.665 | 27.841 | 32.282 | 41.339 | 64.179 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 108.131 | 119.201 | 107.690 | 97.339 | 70.491 |
| 價值變動淨收益/利潤總額(%) | 1.600 | -12.598 | -5.444 | 8.322 | 29.924 |
| 營業外收支淨額/利潤總額(%) | -0.032 | -0.056 | -0.456 | -0.250 | -0.020 | 償債能力分析 |
| 流動比率 (X) | 5.848 | 4.393 | 3.897 | 3.507 | 5.731 |
| 速動比率 (X) | 5.395 | 4.081 | 3.643 | 3.256 | 5.420 |
| 資產負債率 (%) | 10.551 | 14.403 | 16.516 | 17.122 | 11.522 |
| 帶息債務/全部投入資本 (%) | 4.089 | 5.013 | 5.086 | 4.473 | 0.022 |
| 股東權益/帶息債務 (%) | 2,339.171 | 1,887.391 | 1,859.192 | 2,130.120 | 449,460.361 |
| 股東權益/負債合計 (%) | 847.807 | 594.323 | 505.461 | 484.054 | 767.900 |
| 利息保障倍數 (X) | -44.670 | -53.596 | -71.230 | -61.344 | -42.318 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 476.587 | 340.596 | 307.828 | 264.297 | 165.712 |
| 存貨周轉天數 (天) | 917.552 | 759.877 | 570.290 | 500.834 | 334.013 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 29/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
